drugset / Trial / NCT03076970
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
Phase 1
Completed
42 enrolled
Eli Lilly and Company
CoLucid Pharmaceuticals · collabSNBL Clinical Pharmacology Center, Inc. · collab
RandomizedCrossoverTriple-blindBasic science
Summary
This is a randomized, double-blind, three-period, cross-over study to investigate the effect of sumatriptan (Imitrex) 100 mg on the pharmacodynamics and pharmacokinetics of lasmiditan 200 mg.
Timeline
- Start
- 2017-03-21
- Primary completion
- 2017-04-13
- Completion
- 2017-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lasmiditan | Small molecule | 200 mg | Oral |
| Subject | Sumatriptan | Unknown | 100 mg | Oral |